/uploads/5adca156cf30f9882168e01f5241a74c.jpg
[{"id":541,"title":"“2019年提高抗菌药物认识周”宣传材料","cover":null,"position":15,"brief":"每年11月第三周是世界卫生组织确定的“世界提高抗菌药物认识周”。为积极应对细菌耐药带来的挑战,提高抗菌药物科学管理水平,国家卫生健康委医政医管局决定在11月18日-24日组织开展“2019年提高抗菌药物认识周”活动。以“着眼未来 停止过度使用和误用抗菌药物”为主题,通过广泛宣传抗菌药物合理使用知识,提高社会公众和医务人员对细菌耐药危机的认识。现公布抗菌药物合理使用宣传相关材料,供各级卫生健康行政部门和各级各类医疗机构参考使用。","source":"转载","createdAt":"2019-11-19T05:24:32.000Z","clicks":321,"CategoryId":8,"Section":{"route":"law","banner":"/uploads/ed89d5db0ae46b45e819c651e0b253a6.jpg"},"Category":{"cover":"/uploads/5adca156cf30f9882168e01f5241a74c.jpg"}},{"id":540,"title":"中国鲍曼不动杆菌感染诊治与防控专家共识","cover":null,"position":14,"brief":"鲍曼不动杆菌已成为21世纪临床重要致病茵。鲍曼不动杆菌基因组研究发现其具有快速获得和传播耐药性的能力,多重耐药、广泛耐药、全耐药鲍曼不动杆菌已呈世界性流行,成为全球抗感染领域的挑战,更是目前我国最重要的“超级细菌”。由于鲍曼不动杆菌在自然环境、医院环境的广泛存在及在住院患者的多部位定植,临床医生在鲍曼不动杆菌感染的诊断、治疗和预防控制上存在诸多困惑。","source":"转载","createdAt":"2019-11-19T05:21:47.000Z","clicks":336,"CategoryId":8,"Section":{"route":"law","banner":"/uploads/ed89d5db0ae46b45e819c651e0b253a6.jpg"},"Category":{"cover":"/uploads/5adca156cf30f9882168e01f5241a74c.jpg"}},{"id":539,"title":"铜绿假单胞菌下呼吸道感染诊治专家共识","cover":null,"position":13,"brief":"铜绿假单胞菌(Pseudomonas aeruginosa,P.aeruginosa,PA)是一种革兰阴性杆菌,也是临床最常见的非发酵菌,在门然界广泛分布,可作为正常菌群在人体皮肤表面分离到,还可污染医疗器械甚至消毒液,从而导致医源性感染,是医院获得性感染重要的条件致病菌,具有易定植、易变异和多耐药的特点。下呼吸道是医院内细菌感染最常见的发生部位,感染种类主要包括支气管扩张合并感染、慢性阻塞性肺疾病(简称慢阻肺)合并感染和肺炎等,由多重耐药PA(muhidrug resistant P aeruginosa,MDR—PA)引起的下呼吸道感染病死率高,治疗困难,因此规范PA下呼吸道感染的诊断和治疗具有特别重要的意义。","source":"转载","createdAt":"2019-11-19T05:19:46.000Z","clicks":367,"CategoryId":8,"Section":{"route":"law","banner":"/uploads/ed89d5db0ae46b45e819c651e0b253a6.jpg"},"Category":{"cover":"/uploads/5adca156cf30f9882168e01f5241a74c.jpg"}},{"id":536,"title":"耐甲氧西林金黄色葡萄球菌感染防治专家共识2011年更新版","cover":null,"position":10,"brief":"耐甲氧西林金黄色葡萄球菌( Methicillin-resistant staphylococcus aureus,MRSA) 感染的流行是一个严重的临床医学及公共卫生问题。自1961 年首次发现MRSA 以来[1],MRSA 分离率逐年增加,成为医院感染重要的革兰阳性细菌,多重耐药现象日益严重,国外部分地区已出现对万古霉素耐药或中介的金黄色葡萄球菌","source":"转载","createdAt":"2019-11-19T00:00:00.000Z","clicks":364,"CategoryId":8,"Section":{"route":"law","banner":"/uploads/ed89d5db0ae46b45e819c651e0b253a6.jpg"},"Category":{"cover":"/uploads/5adca156cf30f9882168e01f5241a74c.jpg"}},{"id":538,"title":"耐万古霉素肠球菌感染防治专家共识","cover":null,"position":12,"brief":"肠球菌广泛分布在自然界, 常栖居人、动物的肠道和女性泌尿生殖系统, 是人类的正常菌群之一。近年来, 由于抗菌药物的广泛应用, 使原本就对内酰胺类、氨基糖苷类抗菌药物具有内在抗药性的肠球菌耐药性进一步扩大, 逐渐形成了多重耐药菌。在我国, 耐万古霉素肠球菌( vancomycin res istant enterococc,iVRE)感染的发生率呈逐年上升趋势","source":"转载","createdAt":"2019-11-19T00:00:00.000Z","clicks":382,"CategoryId":8,"Section":{"route":"law","banner":"/uploads/ed89d5db0ae46b45e819c651e0b253a6.jpg"},"Category":{"cover":"/uploads/5adca156cf30f9882168e01f5241a74c.jpg"}},{"id":526,"title":"金黄色葡萄球菌细菌肽为全球抗菌药物耐药性带来新的动力","cover":null,"position":8,"brief":"新发现的分离自金黄色葡萄球菌的抗生素不仅对革兰阳性和阴性的多重耐药细菌有效,而且当用于治疗小鼠感染时,新药似乎也不会引发细菌的耐药性。这是Brice Felden教授及其团队在雷恩大学和细菌调控RNA和医学联合实验室(U1230)与雷恩化学科学研究所团队(ISCR)共同创建的两种新抗生素的发现。","source":"转载","createdAt":"2019-08-23T05:54:40.000Z","clicks":463,"CategoryId":8,"Section":{"route":"law","banner":"/uploads/ed89d5db0ae46b45e819c651e0b253a6.jpg"},"Category":{"cover":"/uploads/5adca156cf30f9882168e01f5241a74c.jpg"}},{"id":527,"title":"美国耳念珠菌“紧急威胁”引发关注","cover":null,"position":9,"brief":"近日,耳念珠菌被美国列为“紧急威胁”的消息引发公众极大关注。这是一种什么样的菌株?对健康威胁到底有多大?有哪些易感人群?能否治愈?美国疾病控制和预防中心霉菌病科主任汤姆•奇勒15日就上述问题接受了新华社记者的电话采访。他指出,耳念珠菌对健康人群不构成威胁,无需恐慌。但医疗机构需加强对这种真菌的监测,早发现早治疗是有效应对疾病蔓延的关键。","source":"转载","createdAt":"2019-08-23T00:00:00.000Z","clicks":142,"CategoryId":8,"Section":{"route":"law","banner":"/uploads/ed89d5db0ae46b45e819c651e0b253a6.jpg"},"Category":{"cover":"/uploads/5adca156cf30f9882168e01f5241a74c.jpg"}},{"id":422,"title":"国家卫生计生委办公厅关于成立抗菌药物临床应用与细菌耐药评价专家委员会通知","cover":null,"position":3,"brief":"为落实《遏制细菌耐药国家行动计划(2016-2020年)》(国卫医发〔2016〕43号)有关工作要求,加强抗菌药物临床应用与细菌耐药综合评价,遏制细菌耐药,决定成立国家卫生计生委抗菌药物临床应用与细菌耐药评价专家委员会。","source":"转载","createdAt":"2017-01-11T00:00:00.000Z","clicks":16885,"CategoryId":8,"Section":{"route":"law","banner":"/uploads/ed89d5db0ae46b45e819c651e0b253a6.jpg"},"Category":{"cover":"/uploads/5adca156cf30f9882168e01f5241a74c.jpg"}},{"id":423,"title":"国家卫生计生委办公厅关于提高二级以上综合医院细菌真菌感染诊疗能力的通知","cover":null,"position":4,"brief":"为贯彻落实国家卫生计生委、国家发展改革委等14部门联合印发的《遏制细菌耐药国家行动计划(2016-2020年)》,提高二级以上综合医院细菌真菌感染诊疗能力,促进抗菌药物合理应用,维护人民群众健康,现就有关要求通知如下","source":"转载","createdAt":"2016-12-09T00:00:00.000Z","clicks":1807,"CategoryId":8,"Section":{"route":"law","banner":"/uploads/ed89d5db0ae46b45e819c651e0b253a6.jpg"},"Category":{"cover":"/uploads/5adca156cf30f9882168e01f5241a74c.jpg"}},{"id":421,"title":"关于印发遏制细菌耐药国家行动计划(2016-2020年)的通知","cover":null,"position":2,"brief":"为积极应对细菌耐药带来的挑战,提高抗菌药物科学管理水平,遏制细菌耐药发展与蔓延,维护人民群众身体健康,促进经济社会协调发展,国家卫生计生委等14部门联合制定了《遏制细菌耐药国家行动计划(2016-2020年)》","source":"转载","createdAt":"2016-08-25T00:00:00.000Z","clicks":1182,"CategoryId":8,"Section":{"route":"law","banner":"/uploads/ed89d5db0ae46b45e819c651e0b253a6.jpg"},"Category":{"cover":"/uploads/5adca156cf30f9882168e01f5241a74c.jpg"}},{"id":425,"title":"解读《遏制细菌耐药国家行动计划(2016-2020年)》","cover":null,"position":6,"brief":"近日,国家卫生计生委、发展改革委等14个部门联合印发了《遏制细菌耐药国家行动计划(2016-2020年)》(以下简称《行动计划》)。","source":"转载","createdAt":"2016-08-25T00:00:00.000Z","clicks":1078,"CategoryId":8,"Section":{"route":"law","banner":"/uploads/ed89d5db0ae46b45e819c651e0b253a6.jpg"},"Category":{"cover":"/uploads/5adca156cf30f9882168e01f5241a74c.jpg"}},{"id":424,"title":"国家卫生计生委等12部门召开应对细菌耐药工作会议","cover":null,"position":5,"brief":"2016年4月8日,国家卫生计生委会同发展改革委、教育部、科技部、工业和信息化部、国土资源部、环境保护部、农业部、文化部、食品药品监管总局、中医药管理局、中央军委后勤保障部共计12个部门召开了应对细菌耐药联防联控工作机制第一次会议。","source":"转载","createdAt":"2016-04-11T00:00:00.000Z","clicks":973,"CategoryId":8,"Section":{"route":"law","banner":"/uploads/ed89d5db0ae46b45e819c651e0b253a6.jpg"},"Category":{"cover":"/uploads/5adca156cf30f9882168e01f5241a74c.jpg"}},{"id":426,"title":"卫生部办公厅关于加强多重耐药菌医院感染控制工作的通知","cover":null,"position":7,"brief":"近年来,多重耐药菌(MDRO)已经逐渐成为医院感染的重要病原菌。为加强多重耐药菌的医院感染管理,有效预防和控制多重耐药菌在医院内的传播,保障患者安全,现将有关要求通知如下:","source":"转载","createdAt":"2008-07-15T00:00:00.000Z","clicks":1228,"CategoryId":8,"Section":{"route":"law","banner":"/uploads/ed89d5db0ae46b45e819c651e0b253a6.jpg"},"Category":{"cover":"/uploads/5adca156cf30f9882168e01f5241a74c.jpg"}},{"id":420,"title":"关于建立抗菌药物临床应用及细菌耐药监测网的通知","cover":null,"position":1,"brief":"为贯彻落实《抗菌药物临床应用指导原则》,加强医疗机构抗菌药物临床应用的监督和管理,促进合理用药,提高我国抗菌药物临床应用水平,保护患者用药权益,卫生部、国家中医药管理局和总后卫生部决定建立全国“抗菌药物临床应用监测网”和“细菌耐药监测网”,委托中华医院管理学会药事管理专业委员会和北京大学临床药理研究所分别负责两个监测网的总体规划设计、运行工作及第一批109所医院的抗药物临床应用监测和细菌耐药监测工作。","source":"转载","createdAt":"2005-11-29T00:00:00.000Z","clicks":182,"CategoryId":8,"Section":{"route":"law","banner":"/uploads/ed89d5db0ae46b45e819c651e0b253a6.jpg"},"Category":{"cover":"/uploads/5adca156cf30f9882168e01f5241a74c.jpg"}}]